GRAY NANCY RYAN sold 44.8% of their position (6.57K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.35M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.56K
Price / share
$66.19
Trade value
$235.37K
% of position
Common Stock
Shares
−3.56K
Price / share
$205.45
Trade value
$730.58K
% of position
Common Stock
Shares
+3.02K
Price / share
$73.57
Trade value
$221.81K
% of position
Common Stock
Shares
−3.02K
Price / share
$205.45
Trade value
$619.43K
% of position
Net shares
+0.00
Net value
-$892.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2025 | M · Option Exercise | +3.56K | $66.19 | $235.37K | 43.9% | 8.09K | 11.65K |
| Common Stock Direct | 11/7/2025 | S · Sale | −3.56K | $205.45 | $730.58K | 30.5% | 11.65K | 8.09K |
| Common Stock Direct | 11/7/2025 | M · Option Exercise | +3.02K | $73.57 | $221.81K | 37.2% | 8.09K | 11.11K |
| Common Stock Direct | 11/7/2025 | S · Sale | −3.02K | $205.45 | $619.43K | 27.1% | 11.11K | 8.09K |
| Total | +0.00 | -$892.83K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
3.56K shares
Shares
−3.56K
Strike price
66.19
Held after
0.00
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
3.02K shares
Shares
−3.02K
Strike price
73.57
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock3.56K shares | 11/7/2025 | M · Option Exercise | −3.56K | 66.19 | — | 0.00 |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock3.02K shares | 11/7/2025 | M · Option Exercise | −3.02K | 73.57 | — | 0.00 |